It's official: We have submitted initial data from the pivotal trial of our COVID-19 vaccine in children 5 to under 12 years of age to the @US_FDA: https://t.co/XORlEFksAs— Albert Bourla (@AlbertBourla) September 28, 2021
It's official: We have submitted initial data from the pivotal trial of our COVID-19 vaccine in children 5 to under 12 years of age to the @US_FDA: https://t.co/XORlEFksAs